PharVision Advisers’s QuantumScape Corp QS Stock Holding History

PharVision Advisers’s Portfolio QS Stock Details QS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,864	Closed	-$88.5K	–	114
2026 Q1	$88.5K	Sell	13,864 -3,288	-19%	-$27.3K	0.9%	58
2025 Q4	$179K	Buy	+17,152	New	+$236K	0.09%	591

Other funds holding QS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

CIG

Capricorn Investment Group Palo Alto, California $22.5B AUM 50.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PharVision Advisers's QS Position: Q2 2026 in Review

PharVision Advisers sold out of QuantumScape Corp (QS) in Q2 2026, closing a stake of 13,864 shares — an estimated $88.5K sold.

PharVision Advisers first reported a position in QS in Q4 2025 and held it in 2 quarters. The position peaked at $179K in Q4 2025. 451 funds tracked by Wall St. Rank hold QS as of Q2 2026.

PharVision Advisers reported no remaining QuantumScape Corp position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 13,864 QuantumScape Corp shares in Q2 2026, an estimated $88.5K.
PharVision Advisers first reported a position in QuantumScape Corp in Q4 2025 and held it in 2 quarters.
PharVision Advisers's QuantumScape Corp position peaked at $179K in Q4 2025.
451 funds tracked by Wall St. Rank held QuantumScape Corp as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.